摘要
目的:探讨喜炎平联合利巴韦林治疗小儿手足口病的临床疗效及安全性。方法:对某院共92例手足口病患儿进行研究,随机分为观察组和对照组各46例。对照组采用利巴韦林治疗,观察组采用喜炎平联合利巴韦林治疗,对比两组临床疗效。结果:观察组临床疗效及各症状消失时间优于对照组,对比具有统计学意义(P<0.05);两组不良反应发生率对比无统计学意义(P>0.05)。结论:喜炎平联合利巴韦林治疗小儿手足口病疗效明显,不良反应发生率较低,安全性高,值得推广应用。
Objective:To explore the clinical efficacy and safety of Xiyanping combined with ribavirin in the treatment of pediatric hand,foot and mouth disease.Methods:A total of 92 children with hand-foot-mouth disease in a hospital were studied and randomly divided into observation group and control group,with 46 cases in each group.The control group was treated with ribavirin,and the observation group was treated with Xiyanping combined with ribavirin,then the clinical effects of the two groups were compared.Results:The clinical effect of the observation group and the disappearance time of each symptom were better than those of the control group,and the comparison was statistically significant(P<0.05).The incidence of adverse reactions between the two groups was not statistically significant(P>0.05).Conclusion:Xiyanping combined with ribavirin has obvious curative effect on pediatric hand-foot-mouth disease,with low incidence of adverse reactions and high safety,which is worthy of promotion and application.
作者
高慧
赵恵雅
Gao Hui;Zhao Huiya(The Seventh Department of Internal Medicine,Kaifeng Children's Hospital,Kaifeng 475000)
出处
《数理医药学杂志》
2021年第1期121-122,共2页
Journal of Mathematical Medicine
关键词
喜炎平
利巴韦林
小儿手足口病
临床疗效
安全性
Xiyanping
ribavirin
pediatric hand-foot-mouth disease
clinical efficacy
safety